| Aβ | Amyloid β |
| AD | Alzheimer’s disease |
| AF | Amyloid fibrils |
| α-syn | α-synuclein |
| AO | Amyloid oligomer |
| AP | Amyloid plaque |
| APC | Antigen presenting cell |
| APP23 | Amyloid precursor protein 23 |
| BBB | Blood-brain barrier |
| CSF | Cerebrospinal fluid |
| CNS | Central nervous system |
| DA | Dopamine |
| DSP-4 | N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine |
| HSP-70 | Heat shock protein 70 |
| LB | Lewy body |
| LC | Locus Coeruleus |
| LPS | Lipopolysaccharide |
| MCI | Mild cognitive impairment |
| MTPT | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NA | Noradrenaline |
| NDD | Neurodegenerative disorders |
| NFT | Neurofibrillary tangle |
| NM | Neuromelanin |
| PAMP | Pathogen-associated molecular pattern |
| PD | Parkinson’s disease |
| PET | Positron emission tomography |
| PPARγ | Peroxisome proliferator-activated receptor-γ |
| PRR | Pattern recognition receptor |
| p-Tau | Hyperphosphorylated tau |
| ROS | Reactive oxygen species |
| SNpc | Substantia nigra pars compacta |
| TJ | Tight junction |
| TLR | Toll-like receptor |
| TSPO | Translocation protein |
| VNS | Vagus nerve stimulation. |